PRIVIUM 1. LLC. 110 WALL STREET • SUITE 1100 • NEW YORK • NY 10005 • USA • STRICTLY PRIVATE AND CONFIDENTIAL NON-DISCLOSURE & NON-CIRCUMVENTION AGREEMENT October 271h, 2010 I am writing in connection with the interest expressed by you in a possible participation in a transaction related to the Privium Generic Insulin (the "Transaction"). In consideration of Privium I, LLC., (PRIVIUM) making confidential information available to you, we would ask you to sign and return a copy of this letter which shall represent the Confidentiality Agreement between us. For the purposes of this agreement, 1. 'Relevant Information' means: a. all information (whether written, oral or in any other form) supplied to you in connection with the Transaction by PRIVIUM; and b. in each case includes documents and information prepared or generated from such information. 2. All Relevant Information shall be kept strictly confidential and you shall not disclose in whole or in part any Relevant Information to any persons other than: a. those of your directors or employees, or the directors or employees of affiliated companies or partners or financing Institutions and their directors or employees as are or are likely to be directly concerned with the transaction and who need to know the Relevant Information (or any part of it) for the purpose of evaluating the Transaction; and b. those of your professional advisers engaged to advise in respect of the Transaction and who need to know the Relevant Information (or any part of it) in order to advise upon the Transaction. Provided that you shall procure that each of these directors, employees and professional advisers to whom Relevant Information is to be disclosed is made aware of and shall adhere to the terms of this agreement as if he were a party to it in your place. You shall be responsible for any breach of this agreement by your directors, employees, affiliates and professional advisers engaged by you to advise